Anticoagulants in Cancer Patients: How Effective?
David Green, MD, PhD
Inhibiting the mTORC Pathway in Antiphospholipid Syndrome
Hillary Maitland, MD, MS
Long-Term Outcomes of Stem-Cell Transplantation for Sickle Cell Disease
David Green, MD, PhD
Capecitabine Equivalent to Infusional 5-Fluorouracil for Rectal Cancer
David H. Ilson, MD, PhD
Michael E. Williams, MD, ScM
Cupric Needs: Copper Is Necessary for Oncogenic BRAF Signaling
Kenneth Y. Tsai, MD, PhD
William J. Gradishar, MD
Bone-Targeted Therapy for Hormone-Responsive Prostate Cancer
Robert Dreicer, MD, MS, FACP
Neoadjuvant Chemotherapy for Resectable Non–Small-Cell Lung Cancer
Anne Tsao, MD
Desmopressin Enhances Procoagulant Activity in Patients with Platelet-Function Defects
David Green, MD, PhD